Cancer

Items 151-160 of 307

per page
Set Descending Direction
  1. Fc (human):FasL, Soluble (human) (rec.)
    AG-40B-0132
    AG-40B-0132-C01010 µg
    CHF 335.00
    AG-40B-0132-30103 x 10 µg
    CHF 670.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of MegaFasL, Soluble (human) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Pr
  2. Fc (human):Grancalcin (human) (rec.)
    AG-40B-0242
    AG-40B-0242-C05050 µg
    CHF 440.00
  3. FTY720 . hydrochloride
    CAS  162359-56-0
    AG-CR1-3587
    AG-CR1-3587-M0011 mg
    CHF 15.00
    AG-CR1-3587-M0055 mg
    CHF 25.00
    AG-CR1-3587-M02525 mg
    CHF 55.00
    FTY720 . hydrochloride
  4. G418 . sulfate
    CAS  108321-42-2
    AG-CN2-0030
    AG-CN2-0030-M250250 mg
    CHF 35.00
    AG-CN2-0030-M500500 mg
    CHF 45.00
    AG-CN2-0030-G0011 g
    CHF 60.00
    AG-CN2-0030-G0055 g
    CHF 190.00
    G418 . sulfate
  5. Ganglioside GD3 . disodium salt
    CAS  62010-37-1
    AG-CN2-9005
    AG-CN2-9005-C500500 µg
    CHF 235.00
    AG-CN2-9005-M0011 mg
    CHF 385.00
    Ganglioside GD3 . disodium salt
  6. GANT61
    CAS  500579-04-4
    AG-CR1-3561
    AG-CR1-3561-M0011 mg
    CHF 60.00
    AG-CR1-3561-M0055 mg
    CHF 130.00
    GANT61
  7. Gardiquimod
    CAS  1020412-43-4
    AG-CR1-3583
    AG-CR1-3583-M0055 mg
    CHF 60.00
    AG-CR1-3583-M02525 mg
    CHF 180.00
    Gardiquimod
  8. GE2270 D2
    CAS  138948-60-4
    AG-CN2-0304
    AG-CN2-0304-M0011 mg
    CHF 110.00
    AG-CN2-0304-M0055 mg
    CHF 380.00
    AG-CN2-0304-M02525 mg
    CHF 1'140.00
    GE2270 D2
  9. GE2270A
    CAS  134861-34-0
    AG-CN2-0303
    AG-CN2-0303-M0011 mg
    CHF 110.00
    AG-CN2-0303-M0055 mg
    CHF 380.00
    AG-CN2-0303-M02525 mg
    CHF 1'140.00
    GE2270A
  10. GeA-69
    CAS  2143475-98-1
    AG-CR1-3706
    AG-CR1-3706-M0011 mg
    CHF 60.00
    GeA-69

Items 151-160 of 307

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.